Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (FCRX) EBIT (2021 - 2025)

Historic EBIT for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to -$24.1 million.

  • Crescent Capital BDC's EBIT rose 1200.93% to -$24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.7 million, marking a year-over-year increase of 651.7%. This contributed to the annual value of -$106.8 million for FY2024, which is 647.05% down from last year.
  • As of Q3 2025, Crescent Capital BDC's EBIT stood at -$24.1 million, which was up 1200.93% from -$25.7 million recorded in Q2 2025.
  • Crescent Capital BDC's EBIT's 5-year high stood at $18.6 million during Q3 2021, with a 5-year trough of -$27.4 million in Q3 2024.
  • Its 5-year average for EBIT is -$12.7 million, with a median of -$25.0 million in 2025.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 2079.05% in 2022, then crashed by 26633.96% in 2023.
  • Crescent Capital BDC's EBIT (Quarter) stood at $13.3 million in 2021, then increased by 20.79% to $16.1 million in 2022, then crashed by 266.34% to -$26.8 million in 2023, then grew by 3.52% to -$25.8 million in 2024, then rose by 6.59% to -$24.1 million in 2025.
  • Its last three reported values are -$24.1 million in Q3 2025, -$25.7 million for Q2 2025, and -$25.0 million during Q1 2025.